Target Selectivity of Trametinib (GSK1120212)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| BRaf-MEK1 | 0.001 nM | Molecular docking (Ki value) | PMC11792713 |
| BRaf-MEK2 | 0.465 nM | Molecular docking (Ki value) | PMC11792713 |
| MEK1 | 4.75 nM | Molecular docking (Ki value) | PMC11792713 |
| MEK2 | 14.40 nM | Molecular docking (Ki value) | PMC11792713 |
| MEK | 250 nM | Data extracted from [Vendor] (selleckchem.com) | PMC10749203 |
Check the
Trametinib (GSK1120212)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Trametinib (GSK1120212) Mechanism of Action: MEK Inhibition in Melanoma Cell Research
- Trametinib (GSK1120212) Clinical Trials
- Trametinib (GSK1120212) Working Concentration | Cell Culture | Treatment
- Trametinib (GSK1120212) Solubility in DMSO
- Trametinib (GSK1120212) Stock Solution
- Trametinib (GSK1120212) Storage
- Trametinib (GSK1120212) Stability
- Trametinib (GSK1120212) Combination Database
- Trametinib (GSK1120212) Molecular Weight
- Trametinib (GSK1120212) SMILES
- Trametinib (GSK1120212) CAS Number
- Trametinib (GSK1120212) Chemical Structure (2D and 3D)
- Trametinib (GSK1120212) Sigma (AMBH2D6F887E)? Try a better option.
- Trametinib (GSK1120212) MedChemExpress (HY-10999)? Try a better option.
- Trametinib (GSK1120212) Cayman (16292)? Try a better option.
- Trametinib (GSK1120212) Cell Signaling Technology (62206)? Try a better option.
- Trametinib (GSK1120212) Tocris (7709)? Try a better option.
- Trametinib (GSK1120212) SDS|MSDS